A message from our Chair

AHSNs have transformed the way the NHS identifies, adopts and spreads promising innovations.

In our first decade we have improved health outcomes and supported economic growth, both individually and working together as the AHSN Network.

Since 2018 our national initiatives have benefited more than 2.3 million patients, and our support to innovators has helped contribute more than £1.8bn to UK PLC, created or safeguarded more than 6,600 jobs, and delivered a return on investment of almost £3 for every pound.

As we begin our third five-year licence, now as Health Innovation Networks, I would like to thank all my colleagues from across the Network and partner organisations for their dedication and support. We will continue to champion and support scale-up of the best healthcare innovations to improve health, support the NHS, and achieve economic growth.

Professor Gary Ford CBE, FMedSci
Chair of the AHSN Network and Chief Executive of Oxford AHSN


The AHSN Network Impact Report 2022-23


Download the Impact Report.


2022-23 impacts


National impacts 2022-23 - More than 530,000 patients have benefitted from our national programmes and initiatives - More than 179,000 hours of healthcare staff capacity released across local and national initiatives - 5,488 interactions with companies - 565 jobs created and 763 jobs safeguarded in companies supported by AHSNs - 184 companies created long-term strategic partnerships - 1,512 innovations in our national pipeline of innovation - Almost £428m investment leveraged by companies supported by AHSNs - 2,831 companies supported

  • Ten principles of health equity for innovators

    “Health equity is the attainment of the highest level of health for ALL people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and social determinants of health — and to eliminate disparities in health and health care.” (health.gov) Within the NHS there [...]

  • Collaborating to improve access and equity of care for sickle cell sufferers

    Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red blood cells that can cause problems because they do not live as long as healthy blood cells and can block blood vessels. This can result in suffers experiencing painful episodes, called sickle cell crises, as well as anaemia, [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made across the system to better support some of our most under-served communities. To maintain this momentum, we must not just embed tackling health and healthcare inequalities in all that we do, [...]